Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 238-914-9 | CAS number: 14852-17-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Justification for type of information:
- Data is from experimental study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Principles of method if other than guideline:
- The study was conducted to findout mortality, clinical signs, necropsy finding and histopathological changes in wistar albino rats by using the given test chemical.
- GLP compliance:
- not specified
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Ethylenediamine, salt with phosphoric acid
- EC Number:
- 238-914-9
- EC Name:
- Ethylenediamine, salt with phosphoric acid
- Cas Number:
- 14852-17-6
- Molecular formula:
- C2H8N2.xH3O4P
- IUPAC Name:
- ethane-1,2-diamine; phosphoric acid
- Test material form:
- solid: particulate/powder
- Details on test material:
- Name of the test chemical: ethylenediamine, salt with phosphoric acid
Molecular Formula: C2H11N2O4P
Molecular Weight: 158.094 g/mol
Physical State: Solid, White powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Institute for Industrial Research & Toxicology
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 7 to 9 weeks
- Weight at study initiation: 200±20g
- Identification:By cage tag and corresponding colour body marking
- Fasting period before study: Fasted overnight prior to treatment. Food was offered three hours after dosing.
- Housing: Groups of three animals of similar sex in polypropylene cages with stainless steel grill top, facilities for food and water bottle, and bedding of clean paddy husk.
- Diet (e.g. ad libitum): Pelleted feed
- Water (e.g. ad libitum): Aqua Guard filter water was kept in PVC bottles, ad libitum
- Acclimation period: One week in experimental room after veterinary examination.
- Randomization:After acclimation and veterinary examination randomly selected in groups of three females.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): temperature between 22-25°C
- Humidity (%): relative humidity 40-60%
- Air changes (per hr): Air conditioned rooms with 10-15 air changes per hour
- Photoperiod (hrs dark / hrs light): illumination cycle set to 12 hours artificial fluorescent light and 12 hours dark.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 2000 mg/kg bw
- Amount of vehicle (if gavage): 10ml/kg bw
DOSAGE PREPARATION (if unusual): Dose preparation of the test article was done freshly, few minutes prior to dosing. Test substance was dissolved in distilled water to obtain final concentration of 200 mg/ml. - Doses:
- Two + one vehicle control
Group I: Dist. water, 10ml/kg body wt.
Group II : 2000 mg/kg body wt.
Group III : 2000 mg/kg body wt. - No. of animals per sex per dose:
- Three (3 females)/step
- Control animals:
- yes
- Remarks:
- Group I: Dist. water, 10ml/kg body wt.
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Mortality: The test compound was administered at different dose level in wistar albino rats observed for mortality at the time interval of 30 minutes, 1hr, 2hr, 4 hr, and 6hr time interval on the day of test compound administration and thereafter twice a day for 14 days.
Body weight: The body weight of all the animals was observed weekly on day 0 (pre treatment), 7th and 14th (post treatment).
Clinical Signs: The treated animals were closely observed for clinical signs of intoxication, first 4 hours and every 1 hrs interval for 24 hrs after dosing and thereafter twice a day for 14 days. All the rats were observed at least twice daily to observe any clinical signs or behavioral changes. These observations included changes in skin and fur, in the eyes and mucous membranes, respiratory, circulatory, central nervous and autonomic nervous systems, somatomotor activity and behavioral changes. The following clinical signs were observed in female mice to characterize the various systemic studies: Salivation, lacrimation, pale mucous membrane, diarrheal feaces, hunched posture, scratching, polyuria, hypoactivity etc.
- Necropsy of survivors performed: yes, necropsy was carried out on all the animals which died during the study or surviving animals were sacrificed at the end of the study to observe any gross pathological changes. - Statistics:
- not specified
Results and discussion
- Preliminary study:
- not specified
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality recorded in any of the Wistar albino rats after administration of the test compound during the entire observation period (14 days).
- Clinical signs:
- other: The test compound did not produce any clinical signs of toxicity at the tested dose level throughout the period of observation.
- Gross pathology:
- NECROPSY FINDING
EXTERNAL
i.Skin- Skin and hair coat was observed wet.
ii.All external orifices- Normal
B. INTERNAL
i. Subcutaneous- No change was observed.
ii. Superficial and deep lymph nodes- No change in mesenteric lymph node.
ABDOMINAL CAVITY
i.Opening and general examination- In the abdominal cavity all the organs were present in normal position.
ii.Spleen- Normal upto highest tested dose level 2000 mg/kg b.wt.
iii.Digestive system- No gross changes were observed in stomach and intestine upto highest tested dose level 2000 mg/kg b.wt.
iv.Liver and biliary ducts- No gross pathological changes were observed
v.Excretory system- No gross pathological changes were observed upto highest tested dose level 2000 mg/kg b.wt.
vi.Adrenal- Observed normal.
vii.Male/female genital organs – Showed normal colour, consistency and no inflammatory changes upto highest tested dose level 2000 mg/kg b.wt.
2. THORACIC CAVITY
i.Opening and general examination- Thoracic cavity was found to be normal without any fluid, mucous or blood etc.
ii.Lungs- observed normal.
iii.Heart- No changes were observed in color and consistency. Heart found normal upto highest tested dose level 2000 mg/kg b.wt.
iv.Thyroid- Normal in shape, size and surface upto highest tested dose level 2000 mg/kg b.wt.
3. CRANIAL CAVITY
Brain- Normal in shape and size. - Other findings:
- not specified
Any other information on results incl. tables
TABLE – 2
SUMMARY OF BODY WEIGHT (GM)
Group |
Day 0 |
Day 7 |
% Gain/loss |
Day 14 |
% Gain/loss |
Group-I distilled water 10ml/kg |
202.40 |
208.90 |
3.21 |
217.40 |
7.41 |
Group-II 2000 mg/kg b. wt |
203.70 |
209.2 |
2.70 |
219.9 |
7.95 |
Group-III 2000 mg/kg b. wt |
201.90 |
208.30 |
3.16 |
216.70 |
7.33 |
TABLE – 3
CLINICAL SIGNS AND MORTALITY
Group: I (Vehicle Control) Dose: 10 ml/kg b.wt
FEMALE RATS
Parameters |
Incidence of clinical signs observed after dosing |
Mortality |
||||||||||||||||||
Day 0 |
DAY |
|||||||||||||||||||
Min |
Hour |
|||||||||||||||||||
30 |
1 |
2 |
4 |
6 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
Total* |
|
Mortality (total) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0/3
|
Clinical Signs |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 = No clinical sign (Normal)
+ = Clinical Sign
TABLE – 3 (Contd.)
CLINICAL SIGNS AND MORTALITY
Group: II Dose: 2000 mg/kg b. wt.
FEMALE RATS
Parameters |
Incidence of clinical signs observed after dosing |
Mortality |
||||||||||||||||||
Day 0 |
DAY |
|||||||||||||||||||
Min |
Hour |
|||||||||||||||||||
30 |
1 |
2 |
4 |
6 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
Total* |
|
Mortality (total) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0/3 |
Clinical Signs |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 = Normal
+ = Mild
++ = Moderate
+++ = High
++++ = Severe
TABLE – 3 (Contd.)
CLINICAL SIGNS AND MORTALITY
Group: III Dose: 2000 mg/kg b.wt
FEMALE RATS
Parameters |
Incidence of clinical signs observed after dosing |
Mortality |
||||||||||||||||||
Day 0 |
DAY |
|||||||||||||||||||
Min |
Hour |
|||||||||||||||||||
30 |
1 |
2 |
4 |
6 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
Total |
|
Mortality (total) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0/3 |
Clinical Signs |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 = Normal
+ = Mild
++ = Moderate
+++ = High
++++ = Severe
TABLE – 4
SUMMARY OF NECROPSY FINDINGS
S. No. |
Fate
|
Wistar albino rats |
||
Dose (mg/kg b. wt) |
||||
Distilled water (10 ml/kg) |
2000
|
2000 |
||
1 |
Terminal sacrifice |
3/3 |
3/3 |
3/3 |
2 |
Found Dead |
0/3 |
0/3 |
0/3 |
3 |
Abnormalities detected |
NAD |
NAD |
NAD |
NAD - No abnormality recorded
TABLE - 5
INDIVIDUAL ANIMAL FATE & NECROPSY FINDINGS
Group: I (Vehicle Control) Dose: 10ml/kg b.wt
FEMALE RATS
Animal ID |
Fate |
Time |
Gross Findings |
20164-1 |
TS |
Day 14 |
NAD |
20164-2 |
TS |
Day 14 |
NAD |
20164-3 |
TS |
Day 14 |
NAD |
Day 0 is the day of dose administration.
TS- Terminal Sacrifice
NAD- No abnormality Detected
TABLE – 5 Contd……..
INDIVIDUAL ANIMAL FATE & NECROPSY FINDINGS
Group: II Dose: 2000 mg/kg b.wt.
FEMALE RATS
Animal ID |
Fate |
Time |
Gross Findings |
20164-4 |
TS |
Day 14 |
NAD |
20164-5 |
TS |
Day 14 |
NAD |
20164-6 |
TS |
Day 14 |
NAD |
Day 0 is the day of dose administration.
TS- Terminal Sacrifice
NAD- No abnormality Detected
FD- Found Dead
TABLE – 5 contd……….
INDIVIDUAL ANIMAL FATE & NECROPSY FINDINGS
Group: III Dose: 2000 mg/kg b.wt.
FEMALE RATS
Animal ID |
Fate |
Time |
Gross Findings |
20164-7 |
TS |
Day 14 |
NAD |
20164-8 |
TS |
Day 14 |
NAD |
20164-9 |
TS |
Day 14 |
NAD |
Day 0 is the day of dose administration.
TS- Terminal Sacrifice
NAD- No abnormality Detected
FD- Found Dead
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified
- Conclusions:
- From the results obtained from present investigation, the LD50 value was considered to be >2000 mg/kg bw. Thus, it can be concluded that the test chemical is non toxic to Wistar albino rats. CLP classification "Not classified"
- Executive summary:
The acute oral toxicity study was conducted under the OECD Guideline-423 for testing of chemicals in wistar albino rats. The healthy wistar albino rats of body weight 200±20 gm were selected for study after acclimatization to standard laboratory condition and divided into test compound and vehicle control group each having three animals. The study was conducted stepwise as follow:
Starting dose 2000 mg/kg body weight: Step-I - The test compound was mixed with distilled water and administered orally at the dose level of 2000 mg/kg body weight (dose volume 10ml/kg) to three female rats. However; vehicle control group treated with the distilled water at the dose level of 10 ml/kg b.wt. The treated animals were closely observed for clinical signs of intoxication during first four hours of test compound administration. Thereafter, all the animals were observed periodically at one hour interval for 24 hrs and twice daily for a period of 14 days. The necropsy was performed on all animals at the termination of the study.
The test compound did not elicit any clinical signs of intoxication throughout the period of observation at the tested dose level 2000 mg/kg body weight. Furthermore, no mortality was recorded at test dose level. Vehicle control group of animals were also free from any mortality and clinical signs. The necropsy finding did not reveal any gross pathological changes at the tested dose level. Furthermore, no gross pathological change was observed in vehicle control group.
Step -II: After 72 hrs, the result of step-I was confirmed by administration of same dose level (2000 mg/kg. b.wt) of test compound in additional three animals of same sex (OECD-423 guidelines) under same test condition.
The test compound administered at the dose level of 2000 mg/kg b.wt did not produce any mortality and clinical sign of intoxication throughout the observation period of 14 days. Body weight of each rat was also recorded on day 7th and 14th showed normal gain as compared to control group. Necropsy was conducted at the end of the study (15th day) on all the animals which did not reveal any gross pathological changes.
From the results obtained from present investigation, the LD50 value was considered to be >2000 mg/kg bw. Thus, it can be concluded that the test chemical is non toxic to Wistar albino rats. CLP classification "Not classified"
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.